Welcome to our dedicated page for Upexi SEC filings (Ticker: UPXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Upexi, Inc. (UPXI) SEC filings page brings together the company’s regulatory disclosures, offering a detailed view of how it presents its Solana-focused digital asset treasury strategy and consumer brands operations to regulators and investors. Upexi’s registration statements and current reports describe its role as a digital asset treasury company centered on Solana (SOL), alongside its activities as a brand owner involved in the development, manufacturing, and distribution of consumer products.
In its S-1 and S-1/A registration statements, Upexi outlines its Solana treasury strategy, including the decision to hold SOL directly on its balance sheet, allocate a significant portion of its assets to this digital asset, and generate digital asset revenue primarily through staking. These filings explain how the company delegates SOL to multiple validators, manages staking and unstaking processes, and addresses liquidity and concentration risks within its staking program.
Upexi’s SEC filings also detail its capital markets transactions, such as private placements of common stock, warrants, and secured convertible notes, as well as shelf registration statements and equity line arrangements. Prospectus disclosures describe how these instruments may be used, the number of shares registered for resale, and the company’s characterization of these activities as part of its approach to financing its Solana treasury and corporate needs.
Current reports on Form 8-K provide additional context, including announcements of earnings releases, investor conference participation, advisory committee additions, and the termination of an asset management agreement that led to an arbitration proceeding. Together, these filings allow readers to track Upexi’s digital asset strategy, consumer brands business, financing structures, and significant corporate events through official SEC documents, which can then be interpreted with the help of AI-powered summaries and highlights.
Upexi, Inc. (Nasdaq: UPXI) filed a Form S-1/A registering up to 48,026,410 common shares for resale by existing holders. The total comprises 12.46 M PIPE shares issued 11 Jul 2025 and 35.57 M shares issuable upon conversion of $151.17 M secured convertible notes signed 16 Jul 2025. No proceeds will accrue to the company; Upexi only covers registration costs.
Shares outstanding would rise from 53.79 M to 89.36 M on full conversion—about 66 % dilution—before another 9.9 M shares tied to options, warrants, debt and preferred stock. The last Nasdaq close cited was $5.06 (16 Jul 2025).
Upexi owns and manufactures consumer brands such as LuckyTail (pet care), PRAX (paraxanthine energy), Cure Mushrooms, Moonwlkr (cannabinoids) and Gumi Labs. Early 2025 management adopted a treasury policy allocating a large portion of excess cash to acquiring and staking Solana (SOL). A $100 M private placement (Apr 2025) and a $50 M PIPE plus the above notes (Jul 2025) fund this strategy. The prospectus details extensive risks: regulatory uncertainty around digital assets, product-liability exposure, supply-chain cost pressures, cybersecurity, and potential Nasdaq delisting.
Upexi is a non-accelerated, smaller-reporting, emerging-growth filer and does not anticipate paying dividends, preferring to reinvest cash in operations and its SOL treasury.
On 30 June 2025, Kathmere Capital Management, LLC, a Pennsylvania-based registered investment adviser, filed a Schedule 13G disclosing a new passive position in Upexi, Inc. (UPXI).
- Shares owned: 2,192,983 Class A shares (CUSIP 39959A205)
- Ownership percentage: 5.9% of the outstanding class
- Voting power: 0 shares (no sole or shared voting authority)
- Dispositive power: Sole dispositive power over the full 2.19 million shares
- Filing basis: Rule 13d-1(b) — ordinary-course, non-control investment by an SEC-registered investment adviser
The filing states the securities were acquired "in the ordinary course of business" and not for the purpose of influencing control. No group membership, subsidiaries, or other reporting persons are identified. This adds a new institutional holder of almost 6%, potentially improving UPXI’s liquidity and visibility, but conveys no activist intent.